Apollo Endosurgery Inc. (NASDAQ: APEN) Starts Presentation at The LD 500
Apollo Endosurgery Inc. (NASDAQ: APEN) is a global medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal complications to the treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total health care costs. Apollo's products are offered in over 75 countries today and include the OverStitch(TM) Endoscopic Suturing System, the OverStitch Sx(TM) Endoscopic Suturing System and the ORBERA(R) Intragastric Balloon. Apollo is dedicated to revolutionizing patient care through the development of endoscopic surgery. For more information, visit the company's website at www.apolloendo.com About…







